Discoveries

Vanderbilt researchers led by Ann Richmond have identified a promising drug combination that targets three key pathways in advanced melanoma, potentially restoring the immune response in patients resistant to standard immunotherapy. Although the work is preclinical, the use of drugs already in clinical trials for other conditions could accelerate testing in humans. Read More

Meet Hannah Waterman, a fifth year Ph.D. candidate in the lab of Alan Cherrington in the Department of Molecular Physiology and Biophysics. Read More

Meet David Stiles, a senior financial analyst for the School of Medicine Basic Sciences. Read More

In addition to fueling cutting-edge research, a new molecular imaging system will serve as a cornerstone resource at the Mass Spectrometry Research Center, which is recognized nationally as a hub for molecular imaging and technology development. It will be made accessible to collaborators across academia, national labs, and industry, ensuring broad impact. Read More

Meet Hannah Schaeffer, administrative manager for the Warren Center for Neuroscience Drug Discovery. Read More

Vanderbilt scientists shed light on how the enteric nervous system—sometimes called the "brain" of the gut—forms and functions, offering insights that may advance treatments for gut motility disorders like irritable bowel syndrome and chronic constipation. Read More

Vanderbilt biochemists find role for lipids in age-related vision loss—and pave the way for potential new therapies. Read More

Richard Gustin, PhD’10, sat down with us to discuss his experience studying basic science and pharmacology at Vanderbilt and how it played a role in his career. Gustin is now a senior director of innovation and strategic initiatives at Neurelis, Inc. Read More

Meet Rosalind “Roz” Johnson, a graduate education program manager who is in charge of the day-to-day activities of the Human Genetics and Neuroscience graduate programs. Read More

Congratulations to our School of Medicine Basic Sciences members who were promoted or received new appointments between April and June 2025. These individuals significantly enrich our pursuit of pathbreaking research and contribute to the growth and success of our school. Read More